A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful and sudden onset of swelling, sometimes resulting in death.
Backlash to affirmative action hits pioneering maternal health program for Black women
For Briana Jones, a young Black mother in San Francisco, a city program called the Abundant Birth Project has been a godsend.
November 24, 2023